Kneba M, Bergholz M, Bolz I, Hulpke M, Bätge R, Schauer A, Krieger G
Department of Hematology/Oncology, Georg-August University, Göttingen, FRG.
Int J Cancer. 1990 Apr 15;45(4):609-13. doi: 10.1002/ijc.2910450406.
We have examined 69 B-cell non-Hodgkin's lymphomas (NHL) for rearrangements of the immunoglobulin (Ig) or T-cell antigen receptor (TCR) genes. The lymphomas were assigned to the categories of the Kiel classification and their B-cell nature was confirmed by immunostaining. Only 2 cases (with CLL) displayed clonal T beta-chain TCR gene rearrangements together with rearranged heavy- and light-chain Ig genes. The remaining 67 lymphomas had a germline beta-chain TCR-gene configuration. Three different patterns of Ig gene rearrangements were identified; (A) presence of both heavy- and light-chain rearrangements (H+L+); (B) rearrangement of heavy-chain gene only (H+L-); (C) heavy- and light-chain genes in germline configuration (H-L-). All the 45 low-grade NHLs and the 4 immunoblastic lymphomas exhibited pattern A and all had their kappa gene rearranged or deleted. Of 24 low-grade lymphomas tested, 13 (54%) had an addition rearrangement of the lambda light-chain gene. In contrast, the 19 high-grade centroblastic (cb) B-NHLs had distinct patterns of Ig-gene rearrangement: 12 with pattern A, 4 with B and 2 with C. In this group only 2 of 17 (12%) cases analyzed had evidence of lambda light-chain rearrangement whereas 12 of 18 (67%) had a kappa gene rearrangement or deletion. In one case expressing sIgM/lambda and with heavy chain Ig-rearrangement, no DNA was available for Ig light-chain analysis.
我们检测了69例B细胞非霍奇金淋巴瘤(NHL)的免疫球蛋白(Ig)或T细胞抗原受体(TCR)基因重排情况。这些淋巴瘤按照 Kiel 分类法进行分类,其B细胞性质通过免疫染色得以确认。仅有2例(慢性淋巴细胞白血病)显示克隆性Tβ链TCR基因重排以及重链和轻链Ig基因重排。其余67例淋巴瘤的β链TCR基因呈种系构型。鉴定出三种不同的Ig基因重排模式:(A)重链和轻链均重排(H + L +);(B)仅重链基因重排(H + L -);(C)重链和轻链基因呈种系构型(H - L -)。所有45例低度NHL和4例免疫母细胞淋巴瘤均呈现模式A,且所有病例的κ基因均发生重排或缺失。在检测的24例低度淋巴瘤中,13例(54%)存在λ轻链基因的额外重排。相比之下,19例高度中心母细胞性(cb)B - NHL具有不同的Ig基因重排模式:12例为模式A,4例为模式B,2例为模式C。在该组中,17例分析病例中仅有2例(12%)有λ轻链重排的证据,而18例中有12例(67%)有κ基因重排或缺失。在1例表达sIgM/λ且重链Ig重排的病例中,未获得用于Ig轻链分析的DNA。